- Home
- MCRB vs GIFT Comparison
MCRB vs GIFT Comparison
Compare MCRB & GIFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MCRB | GIFT |
|---|---|---|
| Founded | 2010 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Catalog/Specialty Distribution |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 47.4M | 39.0M |
| IPO Year | 2015 | 2019 |
Fundamental Metrics
Financial Performance| Metric | MCRB | GIFT |
|---|---|---|
| Price | $4.68 | $0.85 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $14.00 | N/A |
| AVG Volume (30 Days) | 53.3K | ★ 68.5K |
| Earning Date | 05-11-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 52.05 |
| EPS | N/A | ★ N/A |
| Revenue | $789,000.00 | ★ $83,181,716.00 |
| Revenue This Year | N/A | $8.19 |
| Revenue Next Year | N/A | $10.30 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $4.32 | $0.73 |
| 52 Week High | $29.98 | $1.29 |
Technical Indicators
Market Signals| Indicator | MCRB | GIFT |
|---|---|---|
| Relative Strength Index (RSI) | 36.18 | 48.73 |
| Support Level | N/A | $0.84 |
| Resistance Level | $5.65 | $1.11 |
| Average True Range (ATR) | 0.34 | 0.07 |
| MACD | 0.02 | -0.00 |
| Stochastic Oscillator | 10.86 | 20.88 |
Price Performance
Historical ComparisonAbout MCRB Seres Therapeutics Inc.
Seres Therapeutics Inc is a clinical-stage biotechnology company focused on the development of live biotherapeutic candidates. Its pipeline includes candidates such as SER-155 and SER-603, aimed at preventing and treating bacterial infections, antimicrobial resistance, and gastrointestinal immune diseases. The company operates as a single reportable segment, mainly developing microbiome-based therapies targeting bacterial infections, antimicrobial resistance, and gastrointestinal immune diseases.
About GIFT RDE Inc.
Giftify Inc operates in the incentive and rewards industry with a focus on retail, dining, and entertainment experiences, as the owner and operator of digital platforms, CardCash.com, Restaurant.com, and Takeout7.com. CardCash.com is a secondary gift card exchange platform, allowing consumers and retailers to buy and sell gift cards at various scales from several retailers; Restaurant.com is a restaurant-focused digital deals brand, connecting digital consumers and businesses by offering dining, retail, and entertainment deal options at several restaurants and retailers; and Takeout7 is a restaurant technology company offering online ordering solutions and AI-powered digital marketing services. Giftify has one segment, the sale of gift cards and discount certificates to its customers.